Suppression of acute secondary disease by heterologous anti-brain serum.
D000818:Animals; D000906:Antibodies; D000961:Antilymphocyte Serum; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D001921:Brain / Q000276:immunology; D006086:Graft vs Host Disease / Q000517:prevention & control*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D011817:Rabbits / Q000276:immunology; D011833:Radiation Injuries, Experimental / Q000628:therapy*; D013154:Spleen / Q000637:transplantation*; D013950:Thymus Gland / Q000276:immunology; D014183:Transplantation, Heterologous
D000906:Antibodies; D000961:Antilymphocyte Serum